Comment on: Villareal et al. (2009) TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action. Diabetes;59:479-485.
Knop
Filip K
FK
D015992:Body Mass Index; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology* / Q000235:genetics*; D014644:Genetic Variation; D052216:Glucagon-Like Peptide 1 / Q000502:physiology; D004763:Glucagon-Like Peptides / Q000502:physiology; D006801:Humans; D054795:Incretins / Q000502:physiology*; D012307:Risk Factors; D051820:TCF Transcription Factors / Q000235:genetics*; D058118:Transcription Factor 7-Like 2 Protein
D054795:Incretins; D051820:TCF Transcription Factors; C544894:TCF7L2 protein, human; D058118:Transcription Factor 7-Like 2 Protein; D004763:Glucagon-Like Peptides; D052216:Glucagon-Like Peptide 1